Internal Medicine, Hematology & Oncology · Danbury, CT
NPI
1457611196
Since 2012
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
95 Locust Ave
Danbury, CT, 06810
Phone (203) 739-7029
Groups this clinician bills Medicare through
Medicare paid, 2024
$95K
1,581 services
Medicare patients, 2024
354
Average age 77
Drug cost, 2024
$3.4M
1,119 prescriptions
Company payments, 2025
$1,750
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wenli Gao was code 99213 (office e&m - established), 419 times for 228 patients. In total Wenli Gao billed 1,581 services in 26 codes, and Medicare paid $95K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 419 | 228 | $70.03 | $29K |
| 85025 Blood Count | Office | 406 | 129 | $7.59 | $3,084 |
| 99214 Office E&M - Established | Office | 320 | 125 | $107.60 | $34K |
| 36415 Venipuncture Blood Collection | Office | 143 | 93 | $8.65 | $1,237 |
| 99222 Hospital E&M - Initial | Facility | 44 | 44 | $111.93 | $4,925 |
| 99215 Office E&M - Established | Office | 41 | 26 | $157.71 | $6,466 |
| 99232 Hospital E&M - Subsequent | Facility | 38 | 27 | $67.32 | $2,558 |
| 99195 Treatment - Miscellaneous | Office | 35 | 11 | $81.27 | $2,845 |
| 99233 Hospital E&M - Subsequent | Facility | 33 | 24 | $101.12 | $3,337 |
| 99204 Office E&M - New | Office | 19 | 19 | $144.93 | $2,754 |
| 99223 Hospital E&M - Initial | Facility | 12 | 11 | $148.10 | $1,777 |
By year: 2022 $121K for 2,056 services; 2023 $118K for 1,879 services; 2024 $95K for 1,581 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 406 | 129 | $7.59 | $3,084 |
| 36415 Venipuncture Blood Collection | 143 | 93 | $8.65 | $1,237 |
Medicare prescription drug claims, 2024
In 2024, the drug Wenli Gao prescribed most often to Medicare patients was Letrozole, with 147 prescriptions and refills. In total Wenli Gao wrote 1,119 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 147 | 430 | 43 | $4,484 |
| Xarelto Rivaroxaban | 84 | 147 | 19 | $80K |
| Hydroxyurea Generic | 69 | 166 | 18 | $1,625 |
| Eliquis Apixaban | 58 | 109 | 15 | $64K |
| Imbruvica Ibrutinib | 42 | 42 | Under 11 | $711K |
| Tamoxifen Citrate Generic | 31 | 93 | Under 11 | $1,744 |
| Enoxaparin Sodium Generic | 30 | 32 | Under 11 | $8,528 |
| Lenalidomide Generic | 26 | 26 | Under 11 | $366K |
| Exemestane Generic | 24 | 63 | Under 11 | $4,061 |
| Anastrozole Generic | 24 | 72 | Under 11 | $386 |
| Prochlorperazine Maleate Generic | 23 | 23 | 14 | $432 |
| Prednisone Generic | 23 | 31 | Under 11 | $37.53 |
| Alprazolam Generic | 22 | 27 | 11 | $90.26 |
| Valacyclovir Valacyclovir Hcl | 22 | 44 | Under 11 | $1,513 |
| Ondansetron Hcl Generic | 20 | 21 | 16 | $510 |
Brand drugs: 309 claims; generic drugs: 810 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wenli Gao $1,750 ($1,750 in general payments such as food, travel and fees) from 30 companies. The largest payer was Abbvie Inc. with $198.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 8 | $198 |
| Celgene Corporation BMY | 9 | $151 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $150 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $129 |
| Array Biopharma Inc PFE | 7 | $116 |
| Pfizer Inc. PFE | 6 | $86.97 |
| Janssen Biotech, Inc. JNJ | 3 | $77.29 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $75.68 |
| Genentech USA, Inc. ROG.SW | 3 | $66.37 |
| Jazz Pharmaceuticals Inc. JAZZ | 3 | $61.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.